BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26661660)

  • 1. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
    Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Body Composition on Bone Health in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Analyses by Dual-energy Radiograph Absorptiometry and Peripheral Quantitative Computed Tomography.
    Barr RD; Inglis D; Athale U; Farncombe T; Gordon CL
    J Pediatr Hematol Oncol; 2022 Nov; 44(8):423-431. PubMed ID: 35482464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort study.
    Barr R; Nayiager T; Gordon C; Marriott C; Athale U
    BMJ Open; 2015 Jan; 5(1):e006191. PubMed ID: 25603918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia in long-term survivors of cancer in childhood and adolescence: A cross-sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle-bone unit.
    Guolla L; Barr R; Jaworski M; Farncombe T; Gordon C
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30705. PubMed ID: 37807928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on Lopes et al. Adiposity Metabolic Consequences for Adolescent Bone Health.
    Boucher BJ
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Lymphocytic Leukemia: Time to Care for the Survivors.
    Fedele PL; Opat S
    J Clin Oncol; 2024 Jun; 42(17):2005-2011. PubMed ID: 38489567
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females.
    Tariq S; Tariq S; Khaliq S; Abualhamael SA; Baig M
    Front Endocrinol (Lausanne); 2022; 13():1024860. PubMed ID: 36531488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
    van Atteveld JE; Mulder RL; van den Heuvel-Eibrink MM; Hudson MM; Kremer LCM; Skinner R; Wallace WH; Constine LS; Higham CE; Kaste SC; Niinimäki R; Mostoufi-Moab S; Alos N; Fintini D; Templeton KJ; Ward LM; Frey E; Franceschi R; Pavasovic V; Karol SE; Amin NL; Vrooman LM; Harila-Saari A; Demoor-Goldschmidt C; Murray RD; Bardi E; Lequin MH; Faienza MF; Zaikova O; Berger C; Mora S; Ness KK; Neggers SJCMM; Pluijm SMF; Simmons JH; Di Iorgi N
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):622-637. PubMed ID: 34339631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia.
    Morel S; Léveillé P; Samoilenko M; Franco A; England J; Malaquin N; Tu V; Cardin GB; Drouin S; Rodier F; Lippé S; Krajinovic M; Laverdière C; Sinnett D; Lefebvre G; Levy E; Marcil V
    Sci Rep; 2020 Dec; 10(1):21507. PubMed ID: 33299020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines in young survivors of childhood acute lymphocytic leukemia revisited: beyond fat mass.
    Siviero-Miachon AA; Spinola-Castro AM; Andreoni S; Lee MLM; Calixto AR; Geloneze B; Guerra-Junior G
    Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):174-181. PubMed ID: 32871655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.
    Franco-Trepat E; Guillán-Fresco M; Alonso-Pérez A; Jorge-Mora A; Francisco V; Gualillo O; Gómez R
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31394795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia.
    Siviero-Miachon AA; Spinola-Castro AM; de Martino Lee ML; de Castro Monteiro CM; de Camargo Carvalho AC; Calixto AR; Geloneze B; Guerra-Junior G
    Vasc Health Risk Manag; 2015; 11():479-88. PubMed ID: 26316772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial radiotherapy predisposes to abdominal adiposity in survivors of childhood acute lymphocytic leukemia.
    Siviero-Miachon AA; Spinola-Castro AM; Lee ML; Andreoni S; Geloneze B; Lederman H; Guerra-Junior G
    Radiat Oncol; 2013 Feb; 8():39. PubMed ID: 23433104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
    Tsilingiris D; Vallianou NG; Spyrou N; Kounatidis D; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Obes Rep; 2024 Mar; 13(1):1-34. PubMed ID: 38159164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin is a positive predictor of bone mineral density in young survivors of acute lymphocytic leukemia.
    Siviero-Miachon AA; Spinola-Castro AM; de Martino Lee ML; Calixto AR; Geloneze B; Lazaretti-Castro M; Guerra-Junior G
    J Bone Miner Metab; 2017 Jan; 35(1):73-82. PubMed ID: 26661660
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.